Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Taiwan To Order 900,000 Doses Of Relenza As Tamiflu Backstop

This article was originally published in PharmAsia News

Executive Summary

Taiwan's Cabinet has decided to have the government buy 900,000 doses of GlaxoSmithKline's Relenza (zanamivir) flu drug, now considered the most efficient H1N1 treatment. The Department of Health minister said the $20 million purchase would be on top of doses in route from local manufacturers of Roche's Tamiflu (oseltamivir). The minister said Relenza would be provided for medical personnel and others more prone to infection, among them people who have contracted the Tamiflu-resistant strain of H1N1 now spreading. The government plans to buy 2.5 million H1N1 vaccine doses when local drug makers begin making them. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC072410

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel